Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S. Davids, Robert J. Soiffer, Haesook T. Kim et al.|New England Journal of Medicine|2016Cited by 595
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II TrialPhilippe Armand, Leo I. Gordon, Arnon Nagler et al.|Journal of Clinical Oncology|2013Cited by 439
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantationMatthew S. Davids, Philippe Armand, Haesook T. Kim et al.|Blood|2020Cited by 98
Optimal use of G-CSF administration after hematopoietic SCTMeghana V. Trivedi, Edward D. Ball, Sam Martinez et al.|Bone Marrow Transplantation|2009Cited by 69
A global study for acute myeloid leukemia with <i>RARG</i> rearrangementHong‐Hu Zhu, Suning Chen, Ya‐Zhen Qin et al.|Blood Advances|2023Cited by 26